IPCA Laboratories Ltd launches Diulcus to address Diabetic Foot Ulcer (DFU) in India

Mumbai (Maharashtra) [India], August 16: As per the ICMR-INDIAB (2023) study, 10 crore people in India suffer from diabetes, with an additional 13.6 crore people affected by pre-diabetes. This significant health concern positions India to become the diabetes capital of the world by 2030.

In response to this serious healthcare challenge, IPCA Laboratories Ltd proudly announces the launch of Diulcus, a novel product aimed at addressing the challenges of Diabetic Foot Ulcer (DFU) in the Indian market. Diulcus, developed by NovaLead Pharma Pvt Ltd, a pioneer in drug repurposing, represents a significant advancement in the management of DFU. The product has received approval from the Central Drugs Standard Control Organization (CDSCO) and was partially funded by the Biotechnology Industry Research Assistance Council (BIRAC), a Government of India enterprise.

The launch event was graced by esteemed personalities, including Sri. Premchand Godha, Sri AK Jain, Dr. Anil Pareek, Sri Sunil Ghai, and Sri. Supreet Deshpande.

During phase 3 trials in India, Diulcus demonstrated remarkable efficacy, with a 60.3% ulcer closure rate within three months of treatment. Remarkably, patients continued to show an ulcer closure rate of 77.20% over six months, even after stopping treatment at three months. These results are among the best observed for any pharmaceutical preparation used in DFU treatment.

Mr. Premchand Godha, Executive Chairman of IPCA Laboratories Ltd, expressed his enthusiasm about the launch, stating, “With over 15% of diabetic patients suffering from DFU at least once in their lifetime, DFU is the most prevalent complication caused by chronic diabetes. The approval of this patented repurposed drug is significant because DFU is the leading cause for lower limb amputations globally. We are delighted to partner with NovaLead Pharma Pvt Ltd through an IP licensing arrangement to bring Diulcus® for DFU patients in India. It demonstrates IPCA’s commitment towards the patients suffering from unmet medical need and its focus on the diabetes therapy.”

Diulcus will be made available to the patients of DFU by Ipca Laboratories Ltd. (Ipca) through an exclusive IP licensing arrangement with NovaLead for Indian starting August 2024.

Disclaimer: The article is for general information purposes only and should not be construed as professional medical advice. Always consult your doctor before taking any step.

If you have any objection to this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 24 hours.

Related Posts

Rohan Corporation Makes Its Bengaluru Debut With Grand Office Inauguration; Three-day Project Showcase To Follow

Inaugurated by Hon’ble Chief Minister of Karnataka Shri D. K. Shivakumar, the new office will welcome prospective homebuyers and investors for an exclusive project exhibition on November 6, 7 and…

Aelea Commodities Delivers 42% Revenue Growth and 53% EBITDA Growth in H1 FY27, Strengthens Financial Position

Mumbai (Maharashtra) [India], November 4: Aelea Commodities Limited (BSE: 544213), a growing player in the cashew processing and Agri-commodities industry, announced its unaudited financial results for the half year ended…

You Missed

Women’s Entrepreneurship Day 2026: Celebrating Women Turning Ideas into Impact

  • By
  • November 19, 2026
Women’s Entrepreneurship Day 2026: Celebrating Women Turning Ideas into Impact

Global Potato Summit 2026 to Position India as a Global Hub for Potato Processing, Innovation and Exports

  • By
  • November 19, 2026
Global Potato Summit 2026 to Position India as a Global Hub for Potato Processing, Innovation and Exports

GLOBAL BHARAT Unveiled to Connect India with Global Education Leaders

  • By
  • November 19, 2026
GLOBAL BHARAT Unveiled to Connect India with Global Education Leaders

Best Autism Doctor in India – Dr. Prince Kumar, Nationally & Internationally Awarded Autism Expert

  • By
  • November 19, 2026
Best Autism Doctor in India – Dr. Prince Kumar, Nationally & Internationally Awarded Autism Expert

The Eighth Edition Of ‘Lucknow Run 2026’ Witnesses An Enthusiastic Participation, Celebrating Fitness, Unity And Community Spirit

  • By
  • November 19, 2026
The Eighth Edition Of ‘Lucknow Run 2026’ Witnesses An Enthusiastic Participation, Celebrating Fitness, Unity And Community Spirit

Polio may go unnoticed, but its consequences can last a lifetime

  • By
  • November 19, 2026
Polio may go unnoticed, but its consequences can last a lifetime